Clipmarks
Matthew Herperfollowshare
2-29-2008 4:01 PM434 views
Adam Feuerstein at TheStreet.com is asking a pointed question about the way Wyeth and Elan are conducting a big study of their Alzheimer's drug. Why, exactly, are the companies trying to design a new way to measure Alzheimer's symptoms, and is doing so really such a good idea?
Login to Comment.  Not a member yet? Sign up





Embed This Clip In Your Site...


OK